Industries > Pharma > Top 25 Antibiotic Drugs Manufacturers 2018

Top 25 Antibiotic Drugs Manufacturers 2018

US, Europe, Japan, Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, Carbapenems, Others

PUBLISHED: 12 June 2018
PAGES: 250
PRODUCT CODE: PHA0316

Clear
WOOCS 2.2.1

Visiongain forecasts the antibiotic drugs market to increase to $ 43,841.7m in 2022. The market is estimated to grow at a CAGR of 3.4% between 2022 and 2028. In 2017, Pfizer held the largest market share of the antibiotic drugs market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 250-page report you will receive 181 tables and 111 figures– all unavailable elsewhere.

The 250-page report provides clear detailed insight into the top 25 antibiotic drugs manufacturers. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Antibiotic Drugs Market Forecast from 2018-2028, further segmented by type:
• Cephalosporins
• Penicillins
• Fluoroquinolones
• Macrolides
• Carbapenems
• Others

Top 25 Antibiotic Drugs Manufacturers 2018

• This report provides analysis of the leading antibiotic drugs manufacturers in the US, including forecasts from 2018-2028 of the company’s antibiotic drugs revenues, where possible:
• Pfizer: Sulperazon, Unasyn, Zithromax, Dalacin, Merrem/Meropen, Zyvox, Tygacil, Others
• Merck & Co.: Cubicin, Invanz, Avelox, Primaxin, Others
• Johnson & Johnson: Zeftera, Sirturo, Others
• Cubist Pharmaceuticals: Cubicin, Sivextro Oral
• Abbott Laboratories: Baxin, Others
• Eli Lilly & Co.: Vancocin, Ceclor
• Melinta Therapeutics, Inc: Orbactiv, Others

• This report provides analysis of the leading antibiotic drugs manufacturers in Europe, including forecasts from 2018-2028 of the company’s antibiotic drugs revenues, where possible:
• Novartis: Vigamox, Ciprodex, TOBI Podhaler, Cubicin
• GlaxoSmithKline: Ceftin/Zinnat, Augmentin IR, Amoxil, Others
• Bayer: Avelox, Cipro/Cirpobay
• Allergan: Zinforo/Teflaro, Dalbavancin, Others
• Roche: Rocephin
• Sanofi: Targocid, Others
• STADA Arzneimittel: Amoxicillin, Diclofenac Sodium

• This report provides analysis of the leading antibiotic drugs manufacturers in Japan, including forecasts from 2018-2028 of the company’s antibiotic drugs revenues, where possible:
• Shionogi & Co., Ltd.: Flomox/Flumarin, Others
• Taisho Pharmaceutical Holdings: Geninax, Biaxin/Clarith, Zosyn/Tazocin
• Daiichi Sankyo: Cravit, Levaquin, Others
• Meiji Holdings Company, Ltd.: Meiact/Spectracef, Others
• Astellas Pharma: Dificid, Others

• This report provides analysis of the leading antibiotic drugs manufacturers in other countries, including forecasts from 2018-2028 of the company’s antibiotic drugs revenue, where possible:
• Sun Pharmaceutical Industries: Ciprofloxacin Hydrochloride, Others
• Cipla: Amoxicillin, Others
• Lupin: Cefixime, Cephalexin, Others
• Shanghai Pharmaceuticals Holding: Cefotaxime Sodium, Cefotiam Hydrochloride, Ceftriaxone Sodium
• Dr. Reddy’s Laboratories: Cefotaxime Sodium, Cefotiam Hydrochloride, Ceftriaxone Sodium
• TaiGen Biotechnology: Taigexyn

Visiongain’s study is intended for anyone requiring commercial analyses for the top 25 antibiotic drugs manufacturers. You find data, trends and predictions.

Buy our report today Top 25 Antibiotic Drugs Manufacturers 2018: US, Europe, Japan, Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, Carbapenems, Others.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Top 25 Antibiotic Drugs Manufacturers 2018


Download sample pages

Complete the form below to download your free sample pages for Top 25 Antibiotic Drugs Manufacturers 2018


Latest Pharma news

Visiongain Publishes Pharmaceutical Product Information Management System Market Report 2020-2030

Some of the major factors fuelling the growth of global market include significant advantages associated with PIM solutions and inclination towards centralized models among across pharma sector.

19 October 2020

READ

Visiongain Publishes Pulmonary/Respiratory Drug Delivery Market Report 2020-2030

The coronavirus outbreak has negatively impacted all the economies and industries across the globe. Hence, for the next 1-2 years, the global respiratory drug delivery market is expected to take a hit.

12 October 2020

READ

Visiongain Publishes Real-World Evidence (RWE) Solutions Market Report 2020-2030

We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

02 October 2020

READ

Visiongain Publishes mRNA Vaccines Market Report 2021-2031

The development of mRNA vaccines is driven by new biotechnologies and nanotechnologies. Emerging delivery technologies, such as electroporation (EP), innovative vaccine formats like mRNA preventive boost, and new molecular adjuvant technologies are particularly important for mRNA vaccines reaching their potential.

02 October 2020

READ

Categories

Category